Trevi Therapeutics Filed For Mixed Shelf Of Up To $200M
Portfolio Pulse from Charles Gross
Trevi Therapeutics has filed for a mixed shelf offering of up to $200 million. The filing was made with the SEC and the details can be found on their website.
June 29, 2023 | 9:10 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Trevi Therapeutics' filing for a mixed shelf offering of up to $200 million could potentially dilute existing shareholders' equity.
A mixed shelf offering allows a company to issue various types of securities such as stocks, bonds, or other instruments. This could lead to dilution of existing shareholders' equity, which may negatively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100